References
- Carstensen B, Jørgensen ME, Friis S. The epidemiology of diabetes and cancer. Curr Diab Rep. 2014;14:535.
- Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–2764.
- Barone BB, Yeh HC, Snyder CF, et al. Postoperative mortality in cancer patients with preexisting diabetes. Systematic review and meta-analysis. Diabetes Care. 2010;33:931–939.
- Stein KB, Snyder CF, Barone BB, et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci. 2010;55:1839–1851.
- Cai H, Xu Z, Xu T, et al. Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies. Diabetes Metab Res Rev. 2015;31:336–343.
- Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29:40–46.
- Renehan AG, Yeh HC, Johnson JA, et al. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia. 2012;55:1619–1632.
- Mills KT, Bellows CF, Hoffman AE, et al. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56:1304–1319.
- Zhang D, Zhao Y, Wang T, et al. Diabetes mellitus and long‐term mortality of ovarian cancer patients. A systematic review and meta‐analysis of 12 cohort studies. Diabetes Metab Res Rev. 2017;33:e2868.
- Zanders MM, Vissers PA, Haak HR, et al. Colorectal cancer, diabetes and survival: epidemiological insights. Diabetes Metab. 2014;40:120–127.
- Leon DA. Trends in European life expectancy: a salutary view. Int J Epidemiol. 2011;40:271–277.
- Healthy life years and life expectancy at birth [Internet]. Luxembourg: Eurostat, European Commission; 2017. [cited 2017 July 5]. Available from: http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&language=en&pcode=tsdph100&plugin =1.
- Public health and morbidity. In: Lepiksone J, editor. Statistical yearbook of health care in Latvia 2015. 17th ed. Riga: Centre for Disease Prevention and Control of Latvia; 2016. p. 67–154.
- Forman D, Bray F, Brewster DH, et al. Cancer Incidence in Five Continents, Vol. X. IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer; 2014.
- WHO Cancer Mortality Database [Internet]. Lyon: International Agency for Research on Cancer. 2010 – [cited 2017 Jan 18]. Available from: http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
- DeAngelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014;15:23–34.
- Minicozzi P, Innos K, Sanchez MJ, et al. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: a EUROCARE-5 study. Eur J Cancer. 2017;84:335–353.
- Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American heart association. Circulation. 1999;100:1134–1146.
- Ranc K, Jørgensen ME, Friis S, et al. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia. 2014;57:927–934.
- Walker JJ, Brewster DH, Colhoun HM, et al. Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia. 2013;56:1531–1541.
- Karanikolos M, Gordeev VS, Mackenbach JP, et al. Access to care in the Baltic States: did crisis have an impact? Eur J Public Health. 2015;26:236–241.
- Country report Latvia 2016. Commission staff working document. Brussels: European Commission; 2016 [cited 2017 Feb 9]. Available from: http://ec.europa.eu/europe2020/pdf/csr2016/cr2016_latvia_en.pdf.
- Porter NR, Eberth JM, Samson ME, et al. Diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system. Prev Chronic Dis. 2016;13:e19.
- Dankner R, Boffetta P, Keinan-Boker L, et al. Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men. Diabetologia. 2016;59:1683–1691.
- Programmas rezultāti [Results of the program]. Riga: The National Health Service of Latvia [Internet]; 2017. [cited 2017 Feb 13]. Available from: http://www.vmnvd.gov.lv/lv/veselibas-aprupes-pakalpojumi/veza-savlaicigas-atklasanas-programma/programmas-rezultati.
- Svarckopfa A, editor. Health survey results of Latvian population, 2009. Riga: Central Statistics Bureau of Latvia; 2010.
- Svarckopfa A, editor. Iedzīvotāju veselības apsekojuma rezultāti, 2016 [Health Survey Results of Latvian Population, 2016]. Riga: Central Statistical Bureau of Latvia; 2016.
- Hosseinpoor AR, Bergen N, Mendis S, et al. Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: results from the World Health Survey. BMC Public Health. 2012;12:474.